Skip to main content
Clinical Trials/NL-OMON46393
NL-OMON46393
Not yet recruiting
Not Applicable

A PROspective, explorative cohort study to correlate CARdiac BIomarkers with late cardiac toxicity induced by radiotherapy alone or combined with anthracycline chemotherapy for hodgkin lymphoma (PROCARBI) - PROCARBI

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
200
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • To be eligible participating in this study, patients must meet all the following criteria:
  • \* Previous history of Hodgkin or mediastinal non\-Hodgkin lymphoma treated with mediastinal radiotherapy with or without anthracycline\-containing chemotherapy
  • \* Planned visit at the BETER clinic
  • \* Written informed consent
  • \* Age \>\<\= 18 years
  • \* With a minimum of 5 years of disease free survival

Exclusion Criteria

  • 4\.3 \* Exclusion criteria;Not currently under treatment for malignant disease (unless basal cell carcinoma)

Outcomes

Primary Outcomes

Not specified

Similar Trials